Alterity Therapeutics Ltd.ASX: ATH

Alterity Granted U.S. FDA Fast Track Designation for ATH434

May 5, 2025 at 3:13 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment